+91-22-48913909
Table of Contents
Best Equity Mutual Funds of 2024
Equity Funds are the ones whose accumulated fund money is invested in equity and equity-related instruments of various companies. The equity funds are considered as a long-term investment option for people having a moderate and high-risk appetite. The various categories of equity funds include Large cap funds, mid cap funds, Small cap funds, ELSS, and so on. In the year 2024, there was an upsurge witnessed in the equity markets due to which most of the equity fund categories have performed well. The performance of these funds depends on a lot of macro and microeconomic parameters such as Industry performance, company performance, the earning and profits of the companies, its future potentials, and so on. The top and Best equity funds for the year 2024 are as follows.
Talk to our investment specialist
Top 10 Equity Mutual Funds of 2024 Based on Performance
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹101.035
↑ 0.60 ₹27,780 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹49.8218
↑ 0.22 ₹887 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹52.4849
↑ 0.38 ₹3,897 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹60.5395
↑ 0.44 ₹12,418 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹176.33
↑ 3.06 ₹6,047 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹279.694
↓ 0.00 ₹1,037 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹420.984
↑ 2.99 ₹3,671 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.5519
↓ -0.01 ₹1,223 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹29.9615
↑ 0.15 ₹518 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹384.202
↑ 3.31 ₹10,724 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 6 Jun 25
Top & Best Equity Mutual Funds of 2024
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 22.8% since its launch. Ranked 27 in Mid Cap category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (06 Jun 25) ₹101.035 ↑ 0.60 (0.60 %) Net Assets (Cr) ₹27,780 on 30 Apr 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.38 Information Ratio 0.46 Alpha Ratio 8.89 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹17,139 31 May 22 ₹21,910 31 May 23 ₹27,996 31 May 24 ₹41,746 31 May 25 ₹49,975 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 6.5% 3 Month 11.8% 6 Month -10% 1 Year 16.3% 3 Year 32.8% 5 Year 36.9% 10 Year 15 Year Since launch 22.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.66 Yr. Niket Shah 1 Jul 20 4.92 Yr. Rakesh Shetty 22 Nov 22 2.52 Yr. Sunil Sawant 1 Jul 24 0.92 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Technology 29.99% Consumer Cyclical 16.64% Industrials 14.58% Health Care 4.76% Communication Services 3.95% Real Estate 3.03% Basic Materials 2.07% Utility 0.35% Financial Services 0.09% Asset Allocation
Asset Class Value Cash 32.1% Equity 67.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹3,078 Cr 3,600,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT10% ₹2,960 Cr 5,250,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL8% ₹2,437 Cr 43,490,250 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB5% ₹1,498 Cr 2,500,000 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA4% ₹1,236 Cr 6,750,000
↑ 250,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON4% ₹1,227 Cr 835,200
↑ 100,000 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | TRENT4% ₹1,210 Cr 2,143,194
↑ 7,450 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433964% ₹1,149 Cr 12,900,814
↑ 512,314 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH4% ₹1,122 Cr 9,969,361 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI3% ₹993 Cr 2,750,000
↑ 50,000 2. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.7% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (06 Jun 25) ₹49.8218 ↑ 0.22 (0.44 %) Net Assets (Cr) ₹887 on 30 Apr 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.03 Information Ratio 0.32 Alpha Ratio 3.02 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,695 31 May 22 ₹19,648 31 May 23 ₹22,758 31 May 24 ₹40,600 31 May 25 ₹44,117 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 16.1% 3 Month 19% 6 Month -4.9% 1 Year 12.9% 3 Year 31.8% 5 Year 33.6% 10 Year 15 Year Since launch 9.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.7 Yr. Mahesh Bendre 1 Jul 24 0.92 Yr. Data below for LIC MF Infrastructure Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 57.02% Basic Materials 9.14% Consumer Cyclical 8.07% Utility 7.19% Financial Services 6.17% Real Estate 3.11% Technology 2.31% Communication Services 2.26% Health Care 0.51% Energy 0.44% Asset Allocation
Asset Class Value Cash 3.8% Equity 96.2% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹34 Cr 408,127 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹30 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹28 Cr 724,927 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001033% ₹24 Cr 1,062,199
↑ 79,197 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹24 Cr 571,332 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 22 | POWERINDIA3% ₹23 Cr 15,928
↑ 2,851 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹22 Cr 537,216
↑ 46,853 Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Oct 23 | HAL2% ₹22 Cr 49,106
↑ 3,972 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹21 Cr 476,469 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹20 Cr 126,914 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized return of 17.3% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (06 Jun 25) ₹52.4849 ↑ 0.38 (0.74 %) Net Assets (Cr) ₹3,897 on 30 Apr 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.08 Information Ratio 0.77 Alpha Ratio 1.58 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,160 31 May 22 ₹16,757 31 May 23 ₹20,100 31 May 24 ₹30,805 31 May 25 ₹35,818 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 15.1% 3 Month 22.6% 6 Month -6.3% 1 Year 17.4% 3 Year 30.1% 5 Year 28.1% 10 Year 15 Year Since launch 17.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.47 Yr. Rakesh Shetty 22 Nov 22 2.52 Yr. Atul Mehra 1 Oct 24 0.66 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 37.3% Consumer Cyclical 20.59% Financial Services 17.43% Technology 8.6% Real Estate 6.27% Basic Materials 5.67% Health Care 2.96% Asset Allocation
Asset Class Value Cash 1.18% Equity 98.82% Top Securities Holdings / Portfolio
Name Holding Value Quantity Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | TRENT6% ₹240 Cr 425,260 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433205% ₹236 Cr 9,923,692 Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL5% ₹213 Cr 1,056,315 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹178 Cr 297,751 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹177 Cr 24,702,337 Inox Wind Ltd (Industrials)
Equity, Since 31 Dec 23 | 5390834% ₹159 Cr 8,173,777 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹156 Cr 240,350 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX4% ₹155 Cr 235,083 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹155 Cr 1,055,205 Bharat Electronics Ltd (Industrials)
Equity, Since 30 Apr 24 | BEL3% ₹152 Cr 3,950,000 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized return of 17.6% since its launch. Ranked 5 in Multi Cap category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (06 Jun 25) ₹60.5395 ↑ 0.44 (0.74 %) Net Assets (Cr) ₹12,418 on 30 Apr 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.39 Information Ratio 0.62 Alpha Ratio 8.34 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹15,277 31 May 22 ₹14,553 31 May 23 ₹16,190 31 May 24 ₹23,601 31 May 25 ₹28,151 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 5.3% 3 Month 10.6% 6 Month -5.3% 1 Year 17.3% 3 Year 25.3% 5 Year 22.1% 10 Year 15 Year Since launch 17.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.66 Yr. Niket Shah 1 Jul 22 2.92 Yr. Rakesh Shetty 22 Nov 22 2.52 Yr. Atul Mehra 1 Oct 24 0.66 Yr. Sunil Sawant 1 Jul 24 0.92 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Technology 22.43% Industrials 18.22% Consumer Cyclical 17.08% Financial Services 8.53% Communication Services 8.52% Health Care 1.73% Consumer Defensive 0.54% Asset Allocation
Asset Class Value Cash 23.56% Equity 76.44% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE11% ₹1,389 Cr 1,625,000
↓ -100,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT10% ₹1,240 Cr 2,200,000 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB9% ₹1,164 Cr 1,942,305
↓ -57,570 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL8% ₹1,009 Cr 18,000,000
↑ 114,380 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | CGPOWER6% ₹841 Cr 12,250,000
↑ 175,830 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | TRENT6% ₹787 Cr 1,394,889 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN6% ₹720 Cr 4,500,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901575% ₹701 Cr 4,999,500 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 May 25 | 5433203% ₹413 Cr 17,331,906
↑ 17,331,906 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 25 | BHARTIARTL3% ₹409 Cr 2,200,826
↑ 2,200,826 5. Invesco India Mid Cap Fund
CAGR/Annualized return of 17.1% since its launch. Ranked 38 in Mid Cap category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (06 Jun 25) ₹176.33 ↑ 3.06 (1.77 %) Net Assets (Cr) ₹6,047 on 30 Apr 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.48 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,865 31 May 22 ₹18,479 31 May 23 ₹21,793 31 May 24 ₹31,587 31 May 25 ₹38,644 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 12.7% 3 Month 20.8% 6 Month 1.2% 1 Year 23.5% 3 Year 30.2% 5 Year 30.6% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.56 Yr. Amit Ganatra 1 Sep 23 1.75 Yr. Data below for Invesco India Mid Cap Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Financial Services 26.33% Health Care 18.64% Consumer Cyclical 16.77% Industrials 11.18% Technology 9.21% Basic Materials 7.94% Real Estate 7.87% Communication Services 1.97% Asset Allocation
Asset Class Value Cash 0.07% Equity 99.93% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE5% ₹322 Cr 506,411 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF5% ₹277 Cr 16,854,973 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE4% ₹260 Cr 1,893,617
↑ 236,434 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON4% ₹256 Cr 155,335 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹247 Cr 2,246,434 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹246 Cr 12,506,782 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 5002514% ₹228 Cr 441,151
↑ 20,000 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹220 Cr 431,234 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002714% ₹220 Cr 1,684,103 HDFC Asset Management Co Ltd (Financial Services)
Equity, Since 31 Jan 25 | HDFCAMC3% ₹192 Cr 439,084
↑ 101,760 6. UTI Healthcare Fund
CAGR/Annualized return of 14.9% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (06 Jun 25) ₹279.694 ↓ 0.00 (0.00 %) Net Assets (Cr) ₹1,037 on 30 Apr 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.69 Information Ratio -0.24 Alpha Ratio 0.57 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹15,428 31 May 22 ₹14,002 31 May 23 ₹14,724 31 May 24 ₹21,653 31 May 25 ₹26,840 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 4.2% 3 Month 8.3% 6 Month -3.8% 1 Year 22.9% 3 Year 25.3% 5 Year 21.6% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.08 Yr. Data below for UTI Healthcare Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 97.95% Basic Materials 0.97% Asset Allocation
Asset Class Value Cash 1.08% Equity 98.92% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA12% ₹123 Cr 672,889
↓ -27,111 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹62 Cr 400,000
↓ -20,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹47 Cr 396,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹47 Cr 172,829
↓ -2,056 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹41 Cr 79,763
↑ 5,763 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹38 Cr 275,250 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹34 Cr 56,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹33 Cr 63,840 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹32 Cr 465,000 7. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (05 Jun 25) ₹420.984 ↑ 2.99 (0.71 %) Net Assets (Cr) ₹3,671 on 30 Apr 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.84 Information Ratio 0.73 Alpha Ratio 2.95 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹15,765 31 May 22 ₹14,496 31 May 23 ₹16,693 31 May 24 ₹23,914 31 May 25 ₹29,485 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month -0.3% 3 Month 6.5% 6 Month -2.5% 1 Year 21.7% 3 Year 27.5% 5 Year 23.7% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 91.24% Basic Materials 6.15% Asset Allocation
Asset Class Value Cash 2.6% Equity 97.4% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA14% ₹513 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹243 Cr 400,000
↑ 25,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹231 Cr 2,100,000
↓ -100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹186 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹182 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹176 Cr 840,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹139 Cr 540,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹134 Cr 2,034,372
↓ -65,628 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹117 Cr 800,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.2% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (06 Jun 25) ₹29.5519 ↓ -0.01 (-0.02 %) Net Assets (Cr) ₹1,223 on 30 Apr 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.52 Information Ratio 0.67 Alpha Ratio 1 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹14,898 31 May 22 ₹14,267 31 May 23 ₹15,234 31 May 24 ₹22,508 31 May 25 ₹26,301 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 1.6% 3 Month 6.7% 6 Month -4.1% 1 Year 16.1% 3 Year 23.6% 5 Year 21.1% 10 Year 15 Year Since launch 12.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.23 Yr. Rajat Srivastava 16 Sep 24 0.7 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Health Care 91.11% Basic Materials 2.29% Asset Allocation
Asset Class Value Cash 6.59% Equity 93.41% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA13% ₹157 Cr 854,300
↑ 50,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹76 Cr 490,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA6% ₹76 Cr 615,100
↓ -125,900 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹71 Cr 101,255 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹64 Cr 104,965 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹64 Cr 303,240 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹59 Cr 855,100 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹48 Cr 956,991 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹38 Cr 75,249 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG3% ₹37 Cr 666,121 9. IDBI Small Cap Fund
CAGR/Annualized return of 14.8% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (06 Jun 25) ₹29.9615 ↑ 0.15 (0.50 %) Net Assets (Cr) ₹518 on 30 Apr 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.07 Information Ratio -0.26 Alpha Ratio 5.34 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹19,646 31 May 22 ₹23,499 31 May 23 ₹27,479 31 May 24 ₹40,150 31 May 25 ₹42,017 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 10.2% 3 Month 11.7% 6 Month -13.1% 1 Year 6.2% 3 Year 21.6% 5 Year 32.4% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.92 Yr. Mahesh Bendre 1 Jul 24 0.92 Yr. Data below for IDBI Small Cap Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 29.89% Consumer Cyclical 17.72% Basic Materials 13.84% Consumer Defensive 8.73% Utility 6.59% Financial Services 6.47% Technology 6.16% Health Care 3.85% Communication Services 2.83% Real Estate 0.41% Asset Allocation
Asset Class Value Cash 3.51% Equity 96.49% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN3% ₹18 Cr 390,711
↓ -10,540 JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹17 Cr 2,506,932 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO3% ₹16 Cr 668,754
↓ -42,908 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419743% ₹16 Cr 109,106
↓ -6,221 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹16 Cr 270,441 Enviro Infra Engineers Ltd (Industrials)
Equity, Since 30 Nov 24 | EIEL2% ₹13 Cr 553,566
↑ 44,921 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL2% ₹13 Cr 337,832 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL2% ₹13 Cr 326,140 Hindustan Foods Ltd (Industrials)
Equity, Since 31 Jul 24 | 5191262% ₹13 Cr 236,195
↑ 16,141 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹13 Cr 1,130,075
↑ 45,798 10. L&T Midcap Fund
CAGR/Annualized return of 19.1% since its launch. Ranked 5 in Mid Cap category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (06 Jun 25) ₹384.202 ↑ 3.31 (0.87 %) Net Assets (Cr) ₹10,724 on 30 Apr 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 0.02 Information Ratio -0.27 Alpha Ratio -0.25 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 May 20 ₹10,000 31 May 21 ₹16,596 31 May 22 ₹17,348 31 May 23 ₹19,606 31 May 24 ₹31,028 31 May 25 ₹33,790 Returns for L&T Midcap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jun 25 Duration Returns 1 Month 10.5% 3 Month 18.9% 6 Month -6.7% 1 Year 10.8% 3 Year 26.2% 5 Year 27.3% 10 Year 15 Year Since launch 19.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.7% 2023 40% 2022 1.1% 2021 30.4% 2020 19% 2019 -0.2% 2018 -12% 2017 52.3% 2016 9.8% 2015 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Cheenu Gupta 26 Nov 22 2.51 Yr. Sonal Gupta 1 Oct 23 1.67 Yr. Data below for L&T Midcap Fund as on 30 Apr 25
Equity Sector Allocation
Sector Value Industrials 23.9% Consumer Cyclical 19.05% Financial Services 18.7% Health Care 12.73% Technology 12.54% Consumer Defensive 4.12% Basic Materials 2.54% Utility 2.12% Communication Services 1.86% Real Estate 1.22% Asset Allocation
Asset Class Value Cash 1.21% Equity 98.79% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE5% ₹509 Cr 800,300 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON5% ₹501 Cr 304,800 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH4% ₹478 Cr 4,355,000 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433204% ₹409 Cr 17,596,500 Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT4% ₹387 Cr 727,100
↓ -100,198 Lupin Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5002573% ₹368 Cr 1,757,400 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 5002513% ₹353 Cr 681,700 Indian Hotels Co Ltd (Consumer Cyclical)
Equity, Since 30 Apr 18 | 5008503% ₹345 Cr 4,385,000
↓ -397,177 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Jan 22 | FEDERALBNK3% ₹343 Cr 17,459,100
↓ -1,341,900 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Mar 24 | POWERINDIA3% ₹330 Cr 227,000
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved